- Home
- VRDN vs HQH Comparison
VRDN vs HQH Comparison
Compare VRDN & HQH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRDN
- HQH
- Stock Information
- Founded
- VRDN 2006
- HQH 1986
- Country
- VRDN United States
- HQH United States
- Employees
- VRDN N/A
- HQH N/A
- Industry
- VRDN Medical Specialities
- HQH Finance Companies
- Sector
- VRDN Health Care
- HQH Finance
- Exchange
- VRDN Nasdaq
- HQH Nasdaq
- Market Cap
- VRDN 1.0B
- HQH 826.8M
- IPO Year
- VRDN N/A
- HQH N/A
- Fundamental
- Price
- VRDN $13.97
- HQH $15.35
- Analyst Decision
- VRDN Strong Buy
- HQH
- Analyst Count
- VRDN 12
- HQH 0
- Target Price
- VRDN $38.50
- HQH N/A
- AVG Volume (30 Days)
- VRDN 785.8K
- HQH 183.8K
- Earning Date
- VRDN 05-06-2025
- HQH 01-01-0001
- Dividend Yield
- VRDN N/A
- HQH 11.56%
- EPS Growth
- VRDN N/A
- HQH N/A
- EPS
- VRDN N/A
- HQH 1.09
- Revenue
- VRDN $302,000.00
- HQH N/A
- Revenue This Year
- VRDN N/A
- HQH N/A
- Revenue Next Year
- VRDN $21,976.14
- HQH N/A
- P/E Ratio
- VRDN N/A
- HQH $15.24
- Revenue Growth
- VRDN 4.86
- HQH N/A
- 52 Week Low
- VRDN $9.90
- HQH $14.31
- 52 Week High
- VRDN $27.20
- HQH $17.94
- Technical
- Relative Strength Index (RSI)
- VRDN 56.41
- HQH 46.16
- Support Level
- VRDN $13.37
- HQH $15.12
- Resistance Level
- VRDN $14.18
- HQH $15.45
- Average True Range (ATR)
- VRDN 0.68
- HQH 0.29
- MACD
- VRDN 0.13
- HQH -0.03
- Stochastic Oscillator
- VRDN 75.40
- HQH 21.30
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).
About HQH abrdn Healthcare Investors Shares of Beneficial Interest
abrdn Healthcare Investors Formerly Tekla Healthcare Investors is the United States based non-diversified closed-end management investment company. Its objective is to seek long-term capital appreciation by investing in securities of healthcare companies. In addition, the fund seeks to provide regular distribution of realized capital gains. The fund invests in the securities of public and private companies.